Research information, not medical advice. This page summarises published evidence and registered trials so that you can look further; it does not assess your situation. Talk to your own clinician before acting on anything here. How we select and grade sources
Based on: Carpal Tunnel Syndrome — gene targets, candidate compounds and trials, OSMF Research Tracker (DGIdb, Open Targets, ChEMBL, PubMed and ClinicalTrials.gov data). Numbers are a snapshot taken 28 October 2026; the tracker page is the live version.
Full trial data → The Carpal Tunnel Syndrome pipeline page on the Research Tracker has every candidate, gene target and trial, with evidence grades.
Short answer: as of October 2026, the OSMF Research Tracker lists 35 candidate medicines for carpal tunnel syndrome that are either approved medicines or have at least one registered clinical trial, built on 8 druggable gene targets, with 15 recent trials on ClinicalTrials.gov. 0 are already approved medicines, for this condition or another one; where the approval is for a different condition, the trial is testing a new use, which is what drug repurposing means. Being in a trial says an intervention is being studied, not that it works; that is what the trial is for.
Which candidates have the most trial activity?
Ranked by the number of registered trials the tracker found. Each trial ID links to the registry entry, where you can read the design, status and sponsor.
- Carpal tunnel release — 2 registered trials · in clinical trials · NCT07594821 NCT07509437
- platelet rich plasma — 2 registered trials · in clinical trials · NCT06249503 NCT02800200
- shock wave — 2 registered trials · in clinical trials · NCT02800200 NCT06214286
- 5% Dextrose — 1 registered trial · in clinical trials · NCT07105540
- Acetaminophen — 1 registered trial · in clinical trials · NCT02313675
- Aquatic Therapy — 1 registered trial · in clinical trials · NCT06905769
- Betamethasone and local anesthetic — 1 registered trial · in clinical trials · NCT07105540
- chirurgie canal carpien — 1 registered trial · in clinical trials · NCT06693167
- Combined carpal tunnel and lacertus release — 1 registered trial · in clinical trials · NCT07594821
- Control group — 1 registered trial · in clinical trials · NCT03802448
- Corticoids — 1 registered trial · in clinical trials · NCT06188221
- CTS-6 Evaluation Tool — 1 registered trial · in clinical trials · NCT07420049
Which gene targets are these built on?
The tracker starts from genes with evidence of being druggable in carpal tunnel syndrome and asks which compounds act on them. Each symbol links to its DGIdb entry, which lists the interacting drugs and the papers behind them: IL6, NR3C1, PTGS2, SCN9A, TGFB1, TNF, TRPV1, TTR.
Which trials are registered?
Drug and biologic treatment trials whose main condition is carpal tunnel syndrome, from the tracker's ClinicalTrials.gov snapshot. Full trial data →
- Ultrasound-Guided Injection of Carpal Tunnel Syndrome Using Hyaluronic Acid vs Corticosteroid vs Glucose 5% NCT07825155 · Recruiting · Phase Early 1 · started 2026-03-15
- Effectiveness of Amniotic Membrane Combined With Secretome as an Adjunct to Carpal Tunnel Release Surgery: Evaluation Using the Boston Carpal Tunnel Questionnaire and Electromyography NCT07723313 · Recruiting · Phase Early 1 · started 2025-12-15
- Comparison of Injection Techniques in Carpal Tunnel Syndrome NCT07105540 · Completed · Phase 4 · started 2025-08-05
- A Study to See Whether Taking a Mix of Vitamins Can Help Adults Recover Better After Surgery for Carpal Tunnel Syndrome NCT07312123 · Recruiting · started 2025-12-08
- A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel Syndrome NCT05306548 · Active Not Recruiting · Phase 4 · started 2022-04-08
- A Study of Fisetin to Treat Carpal Tunnel Syndrome NCT05416515 · Completed · Phase 2 · started 2022-10-09
- Effectiveness of Corticosteroid and 5% Dextrose Versus USG-guided Ozone Injections in Patients With Carpal Tunnel Syndrome: Three Blind Randomized Studies NCT07002892 · Recruiting · started 2025-01-01
- Efficacy And Tolerability Of Alpha Lipoic Acid And Vitamin B Preparation In Carpal Tunnel Syndrome NCT06940557 · Completed · Phase 2/3 · started 2023-12-01
- Ultrasound Guided Activated and Non Activated Platelet Rich Plasma Injection Versus Hydro Dissection by Steroids. NCT06249503 · Completed · Phase 4 · started 2023-02-01
- Comparison of the Efficacy of Different Treatment Methods in Patients With Carpal Tunnel Syndrome NCT05475808 · Active Not Recruiting · Phase 4 · started 2022-08-01
- Does a Different Local Anesthetic Improve Pain After Carpal Tunnel Release? NCT04833777 · Completed · started 2021-07-01
- Ultrasound-Guided 5% Dextrose Injection for Carpal Tunnel Syndrome NCT06349265 · Completed · Phase 4 · started 2023-10-02
- Dextrose, Steroid, PRP: Choosing the Right Injection for CRS Relief; a RCT NCT06349824 · Completed · Phase 4 · started 2023-10-10
- Comparıson Of Electromyography Results Before And After Vıtamın D Treatment In Patıents Wıth Carpal Tunnel Syndrome NCT06282640 · Completed · Phase 4 · started 2021-12-30
- Study of Single Platelet-Rich Plasma Local Injection Vs. Single Corticosteroid Local Injection in Carpal Tunnel Syndrome NCT06209957 · Completed · Phase 4 · started 2017-06-01
How to read this
Evidence is graded on the tracker page in three tiers: clinical (tested in people), mechanistic (a documented action on the target) and correlative (an association in the literature). Most candidates sit in the lower tiers, and many trials are small or early-phase. The list is restricted to medicines and supplements: trial arms that are devices, procedures, behavioural programmes or measurements are filtered out automatically, so an occasional misclassified entry is possible; the tracker page lists every arm. The purpose of this list is to show where the research is, with sources, so that patients, clinicians and researchers can look further; it is not a ranking of what to take. How sources are chosen, graded and corrected is set out in our editorial policy.
More Chronic Disease notes
Related on this site
Research information, not medical advice. Decisions about any medicine belong with you and your clinician. The underlying data are open (CC BY 4.0) and refreshed daily; this note was generated from the tracker page on 28 October 2026.